University Hospitals Case Medical Center Experts Present at ASCO Annual Meeting

CLEVELAND, June 1, 2012 /PRNewswire/ --In a Phase 2 study presented at the 48th Annual Meeting of the American Society for Clinical Oncology (ASCO), clinical researchers from University Hospitals Case Medical Center's Seidman Cancer Center developed a more effective way to treat gynecologic cancers, shortening radiation treatment time from five weeks to three days.The new method, stereotactic body radiotherapy (SBRT), has been used on other types of cancer, but University Hospitals Case Medical Center is the first treatment facility to apply it to gynecologic cancers.

"Unlike traditional radiation therapy, SBRT uses focused radiation beams and targets well-defined tumors," says Charles Kunos, MD, study co-author and Director of Gynecologic Radiation Oncology at University Hospitals Case Medical Center and Associate Professor at Case Western Reserve University School of Medicine. "The highly specific nature of the procedure not only shortens treatment time, it limits the effect of the radiation on healthy tissues."

Dr. Kunos will present the study's findings during a general poster session on gynecologic cancer at ASCO on Sunday, June 3 from 8:00 a.m. 12:00 p.m.

Researchers from University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine will present new research findings in 29 presentationsat ASCO, taking place June 1-5 in Chicago.

"The breadth and depth of this innovative cancer research presented at ASCO is truly outstanding," says Stan Gerson, MD, Director of the Seidman Cancer Center at UH Case Medical Center and the Case Comprehensive Cancer Center at Case Western Reserve University. "Our faculty members are making tremendous advances in hematology and oncology which is reflected in their being chosen for oral and poster presentations."

Other presentations of note include:

Sunday, June 3

General Poster Session: Gynecologic Cancer

Association of smoking with pulmonary recurrences among women with intermediate- to high-risk early-stage endometrial adenocarcinoma.

Abstract #5089: 8:00 a.m. 12:00 p.m.

See the original post:

University Hospitals Case Medical Center Experts Present at ASCO Annual Meeting

Related Posts

Comments are closed.